In the latest episode of the “Pharmacy Friends” podcast, join health outcomes experts for a discussion about Prime’s industry-leading research into persistence and adherence of glucagon-like...

What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this...

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

Annual meeting will feature industry research posters and educational sessions

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Pharmacy Friends In the latest episode of the “Pharmacy Friends” podcast, learn the latest insights on legislative trends, cutting-edge drug therapies and more from the 22nd annual event Alex Cook...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Managed Markets Insight & Technology (MMIT)

Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Joseph Leach, M.D., senior vice president and chief medical officer at Prime Therapeutics/Magellan Rx Management, shares more about the RTBC electronic prescription decision support tool

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.